SEC Filing: AstraZeneca update on Nexium investigation
MLex Summary: AstraZeneca has said that a Dutch investigation of the market for the drug Nexium concerns potential foreclosure for generic versions of "certain proton pump inhibitors other than esomeprazole." The...To view the full article, register now.
Already a subscriber? Click here to view full article